CDKN2A and brain cancer: In particular, we exhibited the direct implication of NR5A2 in the activation of specific genes of the Ink4/Arf locus in NSCs, one of the most significant tumour suppressor loci in many organs, including brain cancers, glioblastomas and retinoblastomas39, 40, 41, 42.